| Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML S Haubner, F Perna, T Köhnke, C Schmidt, S Berman, C Augsberger, ... Leukemia 33 (1), 64-74, 2019 | 271 | 2019 |
| Recent developments in immunotherapy of acute myeloid leukemia FS Lichtenegger, C Krupka, S Haubner, T Köhnke, M Subklewe Journal of hematology & oncology 10, 1-20, 2017 | 172 | 2017 |
| CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes M Rapp, MWM Wintergerst, WG Kunz, VK Vetter, MML Knott, D Lisowski, ... Journal of Experimental Medicine 216 (5), 1170-1181, 2019 | 168 | 2019 |
| HLA-independent T cell receptors for targeting tumors with low antigen density J Mansilla-Soto, J Eyquem, S Haubner, M Hamieh, J Feucht, N Paillon, ... Nature Medicine 28 (2), 345-352, 2022 | 104 | 2022 |
| Cancer cell-derived IL-1α induces CCL22 and the recruitment of regulatory T cells GM Wiedemann, MML Knott, VK Vetter, M Rapp, S Haubner, J Fesseler, ... Oncoimmunology 5 (9), e1175794, 2016 | 93 | 2016 |
| Suppression of intratumoral CCL22 by type i interferon inhibits migration of regulatory T cells and blocks cancer progression D Anz, M Rapp, S Eiber, VH Koelzer, R Thaler, S Haubner, M Knott, ... Cancer research 75 (21), 4483-4493, 2015 | 81 | 2015 |
| Characterization of a novel FLT3 BiTE molecule for the treatment of acute myeloid leukemia B Brauchle, RL Goldstein, CM Karbowski, A Henn, CM Li, VL Bücklein, ... Molecular Cancer Therapeutics 19 (9), 1875-1888, 2020 | 43 | 2020 |
| The dipeptidylpeptidase‐IV inhibitors sitagliptin, vildagliptin and saxagliptin do not impair innate and adaptive immune responses D Anz, S Kruger, S Haubner, M Rapp, C Bourquin, S Endres Diabetes, Obesity and Metabolism 16 (6), 569-572, 2014 | 23 | 2014 |
| Cooperative CAR targeting to selectively eliminate AML and minimize escape S Haubner, J Mansilla-Soto, S Nataraj, F Kogel, Q Chang, E de Stanchina, ... Cancer cell 41 (11), 1871-1891. e6, 2023 | 20 | 2023 |
| Integrated multiomic approach for identification of novel immunotherapeutic targets in AML T Köhnke, X Liu, S Haubner, V Bücklein, G Hänel, C Krupka, ... Biomarker Research 10 (1), 43, 2022 | 11 | 2022 |
| Chemotherapy-free combination of obinutuzumab and ibrutinib in first LINE treatment of follicular lymphoma. The alternative study by the german low grade lymphoma study group … C Schmidt, AK Zoellner, V Jurinovic, M Sökler, R Forstpointner, ... Blood 132, 448, 2018 | 9 | 2018 |
| IF-Better Gating: Combinatorial Targeting and Synergistic Signaling for Enhanced CAR T Cell Efficacy S Haubner, J Mansilla-Soto, S Nataraj, X He, JH Park, X Wang, I Rivière, ... Blood 138 (Supplement 1), 2774-2774, 2021 | 8 | 2021 |
| CD33-TIM3 Dual CAR T Cells: Enhancing Specificity While Maintaining Efficacy Against AML Y Wang, W Lu, L Rohrbacher, H Flaswinkel, AJ Emhardt, G Magno, ... Blood 142, 3449, 2023 | 2 | 2023 |
| Target Densities in Malignant and Normal Cells Determine CAR T Cell Efficacy and Off-Target Hematotoxicity S Haubner, J Mansilla-Soto, S Nataraj, F Kogel, Q Chang, E De Stanchina, ... Blood 140 (Supplement 1), 869-870, 2022 | 2 | 2022 |
| Midostaurin reduces Bite® mediated cytotoxicity against acute myeloid leukemia B Lindl, C Krupka, T Chapman-Arvedson, R Kischel, P Kufer, S Haubner, ... Blood 130 (Supplement 1), 2656-2656, 2017 | 2 | 2017 |
| S104: DIFFERENTIAL TARGET PROFILES AND EFFICACY OF ADCLEC. SYN1 AND CD33-CARS IN HUMANIZED AML MODELS S Haubner, J Mansilla-Soto, S Nataraj, F Kogel, Q Chang, E De Stanchina, ... HemaSphere 7, e776231c, 2023 | 1 | 2023 |
| Chimeric receptors targeting adgre2 and/or clec12a and uses thereof M Sadelain, SP Haubner, J Mansilla-Soto, X He, G Shapiro US Patent App. 17/728,183, 2022 | 1 | 2022 |
| Overcoming Heterogeneity in AML with a Novel or-Gated Hitcar-1XX Platform S Haubner, J Mansilla-Soto, A Garcia Angus, Q Chang, E De Stanchina, ... Blood 140 (Supplement 1), 865-866, 2022 | 1 | 2022 |
| Identification of Novel Targets for Antibody or Chimeric Antigen Receptor (CAR) Based Immunotherapy in AML: Characterizing the Surfaceome from Primary Patient Samples T Koehnke, L Xilong, S Haubner, C Krupka, V Solis-Mezarino, F Herzog, ... Blood 130 (Supplement 1), 3968-3968, 2017 | 1 | 2017 |
| Expression der regulatorische-T-Zell-rekrutierenden Chemokine CCL22 und CCL28 im humanen Mammakarzinom S Haubner lmu, 2017 | 1 | 2017 |
